Catalyst Wire Dossier Catalyst Wire Dossier

Vonsetamig

vonsetamig · Regeneron Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Vonsetamig, covering 2026-02-12 to 2026-02-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Learn How Safe and Tolerable Vonsetamig is in Adult Patients With Chronic Kidney Disease (CKD) Who Need Kidney Transplantation and Are Highly Sensitized to Human Leukocyte Antigen (HLA) [Phase 1, Phase 2]

See pricing